Orally administered Polypodium leucotomos extract decreases psoralen-UVA-induced phototoxicity, pigmentation, and damage of human skin.

doi:10.1016/S0190

Skip navigation

Log in or Sign up
Set your institution here

Results
This Paper

Journals
Bookmarks

To show you the PDF, we need your affiliation

(Don't worry, you'll only have to do this once)

Affiliation:

Cancel

Orally administered Polypodium leucotomos extract decreases psoralen-UVA-induced phototoxicity, pigmentation, and damage of human skin.

Maritza A MA Middelkamp-Hup, Madhu A MA Pathak, Concepcion C Parrado, Tomas T Garcia-Caballero, Francisca F Rius-Díaz, Thomas B TB Fitzpatrick and Salvador S González J Am Acad Dermatol 50(1):41-9 (2004) PMID 14699363

The use of psoralen-UVA (PUVA) in patients of skin phototype I to II is limited by side effects of acute phototoxicity and possible long-term carcinogenesis.

DOI: 10.1016/S0190
Version: za2963e q8za4 q8zbc q8zc4 q8zda q8ze8 q8zf6 q8zg9

Referenced by (1)

blog comments powered by Disqus

Find PDF

paper

PDF from publisher
Suppl. info
HTML version

citation

Cite in EndNote
Log in to bookmark
Export to RefWorks

Get permission

Advanced search Close

Limits Clear all Close

To show you the PDF, we need your affiliation

Orally administered Polypodium leucotomos extract decreases psoralen-UVA-induced phototoxicity, pigmentation, and damage of human skin.

paper

citation

Thanks for joining pubget!

Sign up for free.

Log in to Pubget.

Advanced search Close

Limits Clear all Close

To show you the PDF, we need your affiliation

Orally administered Polypodium leucotomos extract decreases psoralen-UVA-induced phototoxicity, pigmentation, and damage of human skin.

paper

citation